Llorens Pharmaceutical Corp. recalls Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyo
Recalled November 22, 2017 · FDA recall D-0081-2018 · Llorens Pharmaceutical
Hazard
Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets. · FDA Class II
Units
19232 bottles
Sold at
Puerto Rico
Description
Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.
Product
Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, Rx Only, 100-count bottle, Manufactured For: Llorens Pharmaceutical Corp., International Division, Miami, FL 33166. NDC: 54859-701-10
Manufacturer(s)
Llorens Pharmaceutical Corp.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →